Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.33 -0.27 (-0.69%)
As of: Oct 1, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Total Debt (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Total Debt of $16.59 billion for Q2 2026, down 3.7% from $17.23 billion a year earlier and down 0.2% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Total Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries posted Total Debt of $16.81 billion, down 5.5% from FY2024.

  • Total Debt has declined for nine consecutive years, with a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • By year, Total Debt came in at $17.78 billion in FY2024 (-10.3%), $19.83 billion in FY2023 (-6.5%), $21.21 billion in FY2022 (-7.9%) and $23.04 billion in FY2021 (-11.1%).
  • The Q2 2026 figure ranks as the lowest quarterly Total Debt since Q2 2016.
  • Year over year, Total Debt has now declined in each of the last 36 quarters, with an average decline of 7.4% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Total Debt ranged from 0.1% (Q1 2026) to 15.2% (Q1 2025).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $16.63 billion (Q1 2026), $16.81 billion (Q4 2025) and $16.79 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Teva Pharmaceutical Industries 46.10 Bn 32.95 Bn 2.15 Bn 16.59 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.59 Bn
Mar 31, 2026 16.63 Bn
Dec 31, 2025 16.81 Bn
Sep 30, 2025 16.79 Bn
Jun 30, 2025 17.23 Bn
Mar 31, 2025 16.65 Bn
Dec 31, 2024 17.78 Bn
Sep 30, 2024 18.98 Bn
Jun 30, 2024 18.64 Bn
Mar 31, 2024 19.64 Bn
Dec 31, 2023 19.83 Bn
Sep 30, 2023 19.97 Bn
Jun 30, 2023 20.68 Bn
Mar 31, 2023 20.69 Bn
Dec 31, 2022 21.21 Bn
Sep 30, 2022 21.27 Bn
Jun 30, 2022 22.08 Bn
Mar 31, 2022 22.92 Bn
Dec 31, 2021 23.04 Bn
Sep 30, 2021 23.75 Bn
API Access

Teva Pharmaceutical Industries Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=TEVA&period=max&api_key=YOUR_API_KEY